Cost-effectiveness of computed tomographic angiography before reoperative coronary artery bypass grafting: A decision-analytic model

Hemal Gada, Milind Y. Desai, Thomas H. Marwick

Research output: Contribution to journalArticle

Abstract

Background: The risks of repeat thoracotomy can be reduced if thoracic multidetector computed tomographic angiography (CTA) is used to guide preventive surgical strategies (PSS: peripheral cardiopulmonary bypass, circulatory arrest, and nonmedian sternotomy). We sought to defne the cost-effectiveness of CTA using a Markov model. Methods and Results: We studied outcomes and costs of CTA and non-CTA strategies in a modeled cohort of 10 000 patients undergoing redo coronary artery bypass grafting. Rates of PSS implementation were anticipated to follow identification of risk by CTA. Transitions, costs, and utilities were informed by our experience and the literature. Sensitivity analyses included testing a range of costs of CTA and PSS on model outcome. In the reference case, cost and quality-adjusted life years accrued with the use of CTA ($74 869, 4.63 quality-adjusted life-years) were slightly higher than nonuse ($73 471, 4.59 quality-adjusted life-years), yielding an incremental cost-effectiveness ratio of $34 950/quality-adjusted life-years. Cost of PSS (equipment and operating time) was the most significant determinant of incremental cost-effectiveness ratio. In the reference case (cost of CTA ≈$300), identification and avoidance of potential procedural difficulties with CTA rendered it cost-effective if the cost of PSS was

Original languageEnglish (US)
Pages (from-to)705-710
Number of pages6
JournalCirculation: Cardiovascular Quality and Outcomes
Volume5
Issue number5
DOIs
StatePublished - Sep 2012
Externally publishedYes

Fingerprint

Coronary Artery Bypass
Cost-Benefit Analysis
Angiography
Costs and Cost Analysis
Quality-Adjusted Life Years
Sternotomy
Thoracotomy
Cardiopulmonary Bypass
Thorax
Equipment and Supplies

Keywords

  • Computed tomography (multidetector)
  • Coronary artery bypass grafting
  • Cost-effectiveness

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Cost-effectiveness of computed tomographic angiography before reoperative coronary artery bypass grafting : A decision-analytic model. / Gada, Hemal; Desai, Milind Y.; Marwick, Thomas H.

In: Circulation: Cardiovascular Quality and Outcomes, Vol. 5, No. 5, 09.2012, p. 705-710.

Research output: Contribution to journalArticle

@article{6faf2aedf38b4f6abff1c2db61f0a4a4,
title = "Cost-effectiveness of computed tomographic angiography before reoperative coronary artery bypass grafting: A decision-analytic model",
abstract = "Background: The risks of repeat thoracotomy can be reduced if thoracic multidetector computed tomographic angiography (CTA) is used to guide preventive surgical strategies (PSS: peripheral cardiopulmonary bypass, circulatory arrest, and nonmedian sternotomy). We sought to defne the cost-effectiveness of CTA using a Markov model. Methods and Results: We studied outcomes and costs of CTA and non-CTA strategies in a modeled cohort of 10 000 patients undergoing redo coronary artery bypass grafting. Rates of PSS implementation were anticipated to follow identification of risk by CTA. Transitions, costs, and utilities were informed by our experience and the literature. Sensitivity analyses included testing a range of costs of CTA and PSS on model outcome. In the reference case, cost and quality-adjusted life years accrued with the use of CTA ($74 869, 4.63 quality-adjusted life-years) were slightly higher than nonuse ($73 471, 4.59 quality-adjusted life-years), yielding an incremental cost-effectiveness ratio of $34 950/quality-adjusted life-years. Cost of PSS (equipment and operating time) was the most significant determinant of incremental cost-effectiveness ratio. In the reference case (cost of CTA ≈$300), identification and avoidance of potential procedural difficulties with CTA rendered it cost-effective if the cost of PSS was",
keywords = "Computed tomography (multidetector), Coronary artery bypass grafting, Cost-effectiveness",
author = "Hemal Gada and Desai, {Milind Y.} and Marwick, {Thomas H.}",
year = "2012",
month = "9",
doi = "10.1161/CIRCOUTCOMES.112.966465",
language = "English (US)",
volume = "5",
pages = "705--710",
journal = "Circulation: Cardiovascular Quality and Outcomes",
issn = "1941-7713",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Cost-effectiveness of computed tomographic angiography before reoperative coronary artery bypass grafting

T2 - A decision-analytic model

AU - Gada, Hemal

AU - Desai, Milind Y.

AU - Marwick, Thomas H.

PY - 2012/9

Y1 - 2012/9

N2 - Background: The risks of repeat thoracotomy can be reduced if thoracic multidetector computed tomographic angiography (CTA) is used to guide preventive surgical strategies (PSS: peripheral cardiopulmonary bypass, circulatory arrest, and nonmedian sternotomy). We sought to defne the cost-effectiveness of CTA using a Markov model. Methods and Results: We studied outcomes and costs of CTA and non-CTA strategies in a modeled cohort of 10 000 patients undergoing redo coronary artery bypass grafting. Rates of PSS implementation were anticipated to follow identification of risk by CTA. Transitions, costs, and utilities were informed by our experience and the literature. Sensitivity analyses included testing a range of costs of CTA and PSS on model outcome. In the reference case, cost and quality-adjusted life years accrued with the use of CTA ($74 869, 4.63 quality-adjusted life-years) were slightly higher than nonuse ($73 471, 4.59 quality-adjusted life-years), yielding an incremental cost-effectiveness ratio of $34 950/quality-adjusted life-years. Cost of PSS (equipment and operating time) was the most significant determinant of incremental cost-effectiveness ratio. In the reference case (cost of CTA ≈$300), identification and avoidance of potential procedural difficulties with CTA rendered it cost-effective if the cost of PSS was

AB - Background: The risks of repeat thoracotomy can be reduced if thoracic multidetector computed tomographic angiography (CTA) is used to guide preventive surgical strategies (PSS: peripheral cardiopulmonary bypass, circulatory arrest, and nonmedian sternotomy). We sought to defne the cost-effectiveness of CTA using a Markov model. Methods and Results: We studied outcomes and costs of CTA and non-CTA strategies in a modeled cohort of 10 000 patients undergoing redo coronary artery bypass grafting. Rates of PSS implementation were anticipated to follow identification of risk by CTA. Transitions, costs, and utilities were informed by our experience and the literature. Sensitivity analyses included testing a range of costs of CTA and PSS on model outcome. In the reference case, cost and quality-adjusted life years accrued with the use of CTA ($74 869, 4.63 quality-adjusted life-years) were slightly higher than nonuse ($73 471, 4.59 quality-adjusted life-years), yielding an incremental cost-effectiveness ratio of $34 950/quality-adjusted life-years. Cost of PSS (equipment and operating time) was the most significant determinant of incremental cost-effectiveness ratio. In the reference case (cost of CTA ≈$300), identification and avoidance of potential procedural difficulties with CTA rendered it cost-effective if the cost of PSS was

KW - Computed tomography (multidetector)

KW - Coronary artery bypass grafting

KW - Cost-effectiveness

UR - http://www.scopus.com/inward/record.url?scp=84868667976&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868667976&partnerID=8YFLogxK

U2 - 10.1161/CIRCOUTCOMES.112.966465

DO - 10.1161/CIRCOUTCOMES.112.966465

M3 - Article

C2 - 22933521

AN - SCOPUS:84868667976

VL - 5

SP - 705

EP - 710

JO - Circulation: Cardiovascular Quality and Outcomes

JF - Circulation: Cardiovascular Quality and Outcomes

SN - 1941-7713

IS - 5

ER -